Abstract: User requests for a web application can be received at a reverse proxy. Web application code for a first application can be obtained. Data can be checked at the reverse proxy to determine whether to insert an element into the first application. If there is a match, a combined web application can be produced, including the first web application and the element.

Abstract: A system and method for facilitating changing a link generated by a script provided in proxied content. The example method includes identifying a link-producing script in proxied content; applying a wrapper function to the link-producing script; and employing the wrapper function to rewrite one or more links output by the link-producing script. In a specific embodiment, the proxied content includes Hypertext Transfer Protocol Language (HTML) markup. The link-producing script is implemented via JavaScript, and one or more links output via the link-producing script includes one or more Uniform Resource Locators (URLs).

Abstract: A system and method for facilitating changing a link generated by a script provided in proxied content. The example method includes identifying a link-producing script in proxied content; applying a wrapper function to the link-producing script; and employing the wrapper function to rewrite one or more links output by the link-producing script. In a specific embodiment, the proxied content includes Hypertext Transfer Protocol Language (HTML) markup. The link-producing script is implemented via JavaScript, and one or more links output via the link-producing script includes one or more Uniform Resource Locators (URLs).

Abstract: The subject invention concerns platinum complexes that exhibit antitumor cell and/or antiparasitic activity. The subject invention also concerns the use of platinum complexes of the invention to treat oncological and inflammatory disorders. The platinum complexes of the invention can also be used to treat or prevent infection by a virus or a bacterial or parasitic organism in vivo or in vitro.

Abstract: The subject invention concerns platinum complexes that exhibit antitumor cell and/or antiparasitic activity. The subject invention also concerns the use of platinum complexes of the invention to treat oncological and inflammatory disorders. The platinum complexes of the invention can also be used to treat or prevent infection by a virus or a bacterial or parasitic organism in vivo or in vitro.

Abstract: The subject invention concerns platinum complexes that exhibit antitumor cell and/or antiparasitic activity. The subject invention also concerns the use of platinum complexes of the invention to treat oncological and inflammatory disorders. The platinum complexes of the invention can also be used to treat or prevent infection by a virus or a bacterial or parasitic organism in vivo or in vitro.

Abstract: The subject invention concerns platinum complexes that exhibit antitumor cell and/or antiparasitic activity. The subject invention also concerns the use of platinum complexes of the invention to treat oncological and inflammatory disorders. The platinum complexes of the invention can also be used to treat or prevent infection by a virus or a bacterial or parasitic organism in vivo or in vitro.

Abstract: Web application code can be interpreted to indicate a pagelet web application. A combined display including a section of the pagelet web application in a page of the first application can then be produced.

Abstract: A reverse proxy server can receive user requests for web applications. Web application code can be obtained for a first web application. A tag in the first web application can be interpreted to indicate a pagelet web application. The pagelet web application code can be obtained from the pagelet web application and a combined presentation produced.

Abstract: A reverse proxy server can receive user requests for web applications. Web application code can be obtained for a first web application. The reverse proxy server can be configured to recognize a specific proxied web application page to indicate a pagelet web application. The pagelet web application code can be obtained from the pagelet web application and a combined presentation produced by inserting the pagelet web application into a specified location in the first web application. This embodiment allows a pagelet web application code to be inserted into a first web application where the first web application code has not been modified prior to the first web application being proxied.

Abstract: The subject invention concerns platinum complexes that exhibit antitumor cell and/or antiparasitic activity. The subject invention also concerns the use of platinum complexes of the invention to treat oncological and inflammatory disorders. The platinum complexes of the invention can also be used to treat or prevent infection by a virus or a bacterial or parasitic organism in vivo or in vitro.

Abstract: The subject invention concerns platinum complexes that exhibit antitumor cell and/or antiparasitic activity. The subject invention also concerns the use of platinum complexes of the invention to treat oncological and inflammatory disorders. The platinum complexes of the invention can also be used to treat or prevent infection by a virus or a bacterial or parasitic organism in vivo or in vitro.

Abstract: The subject invention concerns platinum complexes that exhibit antitumor cell and/or antiparasitic activity. The subject invention also concerns the use of platinum complexes of the invention to treat oncological and inflammatory disorders. The platinum complexes of the invention can also be used to treat or prevent infection by a virus or a bacterial or parasitic organism in vivo or in vitro.

Abstract: The subject invention concerns platinum complexes that exhibit antitumor cell and/or antiparasitic activity. The subject invention also concerns the use of platinum complexes of the invention to treat oncological and inflammatory disorders. The platinum complexes of the invention can also be used to treat or prevent infection by a virus or a bacterial or parasitic organism in vivo or in vitro.

Abstract: User requests for a web application can be received at a reverse proxy. Web application code for a first application can be obtained. Data can be checked at the reverse proxy to determine whether to insert an element into the first application. If there is a match, a combined web application can be produced, including the first web application and the element.

Abstract: A tag in first web application code can be interpreted to indicate a pagelet web application. Code from the pagelet web application can be inserted into a page of the first application.

Abstract: A reverse proxy server can receive user requests for web applications. Web application code can be obtained for a first web application. The reverse proxy server can be configured to recognize a specific proxied web application page to indicate a pagelet web application. The pagelet web application code can be obtained from the pagelet web application and a combined presentation produced by inserting the pagelet web application into a specified location in the first web application. This embodiment allows a pagelet web application code to be inserted into a first web application where the first web application code has not been modified prior to the first web application being proxied.

Abstract: A reverse proxy server can receive user requests for web applications. Web application code can be obtained for a first web application. A tag in the first web application can be interpreted to indicate a pagelet web application. The pagelet web application code can be obtained from the pagelet web application and a combined presentation produced.

Abstract: Web application code can be interpreted to indicate a pagelet web application. A combined display including a section of the pagelet web application in a page of the first application can then be produced.

Abstract: A computer program product, apparatus, and method for use in an authentication server for obtaining access to a secure server for a client that has issued a request for access to the secure server, without further intervention by the user of the client, includes receiving an authentication challenge sent by the secure server to the client; and generating a ticket having a digital signature applied using a private key of the authentication server; and wherein the secure server, upon receiving the ticket and verifying the digital signature using a public key corresponding to the private key of the authentication server, grants access to the client.